An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19

An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19

Show other versions (1)

<h4>Objective</h4> Coronaviruses, hence named because of the crown-like spikes on the viral envelope, are members of Coronaviridae family and Order Nidovirales. SARS-CoV-2 is the seventh human pathogenic coronavirus identified after HCoV-229E, HCoV-OC43, SARS-CoV (SARS-CoV-1), HCoV-NL63,...

Full description

Bibliographic Details
Main Authors: Shan Sasidharan, Hareendran Nair J., Srinivasakumar K. P., Jerin Paul, Madhu Kumar R., Kannan Rajendran, Anita Ajit Saibannavar, Sonali Nirali
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725144/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725144/?tool=EBI

Similar Items